Eight-year follow up results of the OTOASOR Trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer. A randomized, single centre, phase III, non-inferiority trial

被引：0
|
作者：
Savolt, A. [1 ]
Peley, G. [2 ]
Csaba, P. [3 ]
Udvarhelyi, N. [4 ]
Kovacs, E. [5 ]
Gyorffy, B. [6 ]
Matrai, Z. [1 ]
机构：
[1] Natl Inst Oncol, Dept Breast & Sarcoma Surg, Budapest, Hungary
[2] Norfolk & Norwich Univ Hosp, Dept Gen Surg, Norwich, Norfolk, England
[3] Natl Inst Oncol, Ctr Radiotherapy, Budapest, Hungary
[4] Natl Inst Oncol, Dept Pathol, Budapest, Hungary
[5] Natl Inst Oncol, Dept Diagnost Imaging, Budapest, Hungary
[6] Hungarian Acad Sci, MTA TTK Momentum Canc Biomarker Res Grp, Budapest, Hungary
来源：
EUROPEAN JOURNAL OF CANCER | 2017年 / 72卷
关键词：
D O I：
10.1016/S0959-8049(17)30090-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1LBA
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 36 条
  • [31] Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial
    Meattini, Icro
    De Santis, Maria Carmen
    Visani, Luca
    Scorsetti, Marta
    Fozza, Alessandra
    Meduri, Bruno
    De Rose, Fiorenza
    Bonzano, Elisabetta
    Prisco, Agnese
    Masiello, Valeria
    La Rocca, Eliana
    Spoto, Ruggero
    Becherini, Carlotta
    Blandino, Gladys
    Moscetti, Luca
    Ray Colciago, Riccardo
    Audisio, Riccardo A.
    Brain, Etienne
    Caini, Saverio
    Hamaker, Marije
    Kaidar-Person, Orit
    Lambertini, Matteo
    Marrazzo, Livia
    Saieva, Calogero
    Spanic, Tanja
    Vratislav, Strnad
    Wheelwright, Sally
    Poortmans, Philip M. P.
    Livi, Lorenzo
    EUROPA Trial Investigators
    LANCET ONCOLOGY, 2025, 26 (01): : 37 - 50
  • [32] 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer
    Takaki Yoshikawa
    Masanori Terashima
    Junki Mizusawa
    Souya Nunobe
    Yasunori Nishida
    Takanobu Yamada
    Masahide Kaji
    Takashi Nomura
    Shinji Hato
    Yasuhiro Choda
    Hiroshi Yabusaki
    Kazuhiro Yoshida
    Kazunari Misawa
    Toru Masuzawa
    Masahiro Tsuda
    Yasuyuki Kawachi
    Hiroshi Katayama
    Haruhiko Fukuda
    Yukinori Kurokawa
    Narikazu Boku
    Takeshi Sano
    Mitsuru Sasako
    Gastric Cancer, 2024, 27 : 155 - 163
  • [33] 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer
    Yoshikawa, Takaki
    Terashima, Masanori
    Mizusawa, Junki
    Nunobe, Souya
    Nishida, Yasunori
    Yamada, Takanobu
    Kaji, Masahide
    Nomura, Takashi
    Hato, Shinji
    Choda, Yasuhiro
    Yabusaki, Hiroshi
    Yoshida, Kazuhiro
    Misawa, Kazunari
    Masuzawa, Toru
    Tsuda, Masahiro
    Kawachi, Yasuyuki
    Katayama, Hiroshi
    Fukuda, Haruhiko
    Kurokawa, Yukinori
    Boku, Narikazu
    Sano, Takeshi
    Sasako, Mitsuru
    GASTRIC CANCER, 2024, 27 (01) : 155 - 163
  • [34] 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer
    Kim, Hyung-Don
    Ryu, Min-Hee
    Lee, Ji Sung
    Kang, Yoon-Koo
    GASTRIC CANCER, 2024, 27 (04) : 884 - 885
  • [35] Predictors of early, intermediate, and late recurrences in randomized phase III trial of adjuvant chemotherapy versus chemoimmunotherapy for locally advanced gastric cancer after curative surgery: Final results of 15-year follow-up
    Moon, Y.
    Jeung, H.
    Rha, S.
    Yoo, N.
    Roh, J.
    Noh, S.
    Min, J.
    Kim, B.
    Chung, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Refusal of breast surgery in breast cancer patients with clinical complete response (cCR) after neoadjuvant systemic therapy and vacuum-assisted biopsy (VAB) and sentinel lymph node biopsy (SLNB) confirmed pathological complete response (pCR). A first report of the prospective non-randomized trial results. NCT04293796
    Krivorotko, Petr
    Yerechshenko, Sergey
    Emelyanov, Alexander
    Busko, Ekaterina
    Bessonov, Alexander
    Gukova, Viktoriya
    Komyahov, Alexander
    Zhiltsova, Elena
    Nikolaev, Kirill
    Tabagua, Tengiz
    Gigolaeva, Larisa
    Pesotsky, Roman
    Novikov, Sergey
    Bryantseva, Zhanna
    Artemyeva, Anna
    Smirnova, Viktoriya
    Kushnarev, Vladimir
    Belyaev, Alexey
    Semiglazova, Tatiana
    Semiglazov, Vladimir
    CANCER RESEARCH, 2022, 82 (04)
1234